CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

From cardiac ablation devices to OTC glucose sensors, explore how breakthrough medical technologies are disrupting ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall ...

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.

The 100% duties will begin Nov. 1 and stack on existing levies, the president said Friday, seemingly squashing a months-long trade truce.

The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion ...

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...